# Cerdelga

NDC: 58468-0220
Generic name: eliglustat
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20140903

FDA application: NDA205494

## Active ingredients

- ELIGLUSTAT: 84 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0220"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0220
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=819f828a-b888-4e46-83fc-94d774a28a83
